[Juvenile GM2 gangliosidosis with altered substrate specificity of hexosaminidase A (author's transl)]. 1974

J Zerfowski, and K Sandhoff

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D009438 Neuraminic Acids Nine-carbon deoxyamino SUGAR ACIDS that are substrates for NEURAMINIDASE. Their derivatives include SIALIC ACIDS. Acids, Neuraminic
D002518 Ceramides Members of the class of neutral glycosphingolipids. They are the basic units of SPHINGOLIPIDS. They are sphingoids attached via their amino groups to a long chain fatty acyl group. They abnormally accumulate in FABRY DISEASE. Ceramide
D005260 Female Females
D005688 Galactosamine
D006596 Hexosaminidases Enzymes that catalyze the hydrolysis of N-acylhexosamine residues in N-acylhexosamides. Hexosaminidases also act on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES. Galactosaminidases,Hexosaminidase,Galactosaminidase,Glucosaminidase,Glucosaminidases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D013106 Sphingolipidoses A group of inherited metabolic disorders characterized by the intralysosomal accumulation of SPHINGOLIPIDS primarily in the CENTRAL NERVOUS SYSTEM and to a variable degree in the visceral organs. They are classified by the enzyme defect in the degradation pathway and the substrate accumulation (or storage). Clinical features vary in subtypes but neurodegeneration is a common sign. Sphingolipid Storage Diseases,Sphingolipidosis,Sphingolipid Storage Disease,Storage Disease, Sphingolipid,Storage Diseases, Sphingolipid

Related Publications

J Zerfowski, and K Sandhoff
December 1970, The Journal of pediatrics,
J Zerfowski, and K Sandhoff
September 1970, Neurology,
J Zerfowski, and K Sandhoff
April 1971, Neurology,
J Zerfowski, and K Sandhoff
January 1987, Journal of inherited metabolic disease,
J Zerfowski, and K Sandhoff
January 2009, Molecular genetics and metabolism,
J Zerfowski, and K Sandhoff
December 1971, Pediatrie,
J Zerfowski, and K Sandhoff
April 1970, Neurology,
J Zerfowski, and K Sandhoff
July 1983, American journal of human genetics,
J Zerfowski, and K Sandhoff
January 2008, Clinical neuropathology,
Copied contents to your clipboard!